Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02759172 · ClinicalTrials.gov registry record · NA

Suicide Prevention Intervention for At-Risk Individuals in Transition

A NA study of Suicide, sponsored by Michigan State University.

Completed
Registry status
NA
Development phase
800
Enrollment target
2
Study locations

NCT02759172 is a NA study of Suicide that has completed, run by Michigan State University. The registered enrollment target is 800 participants, below the 6,981-participant average among 92 other Suicide trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02759172, a NA study of Suicide, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
NA
Development phase
800 participants
Enrollment target
2
Study locations

Study Summary

The four year SPIRIT Trial, or Suicide Prevention Intervention for at-Risk Individuals in Transition, will recruit 800 pretrial jail detainees at risk for suicide. Each participant will be randomly assigned to today's standard care or to Safety Planning Intervention (SPI) method and then followed for one year after release. Outcomes include suicide events, suicide attempts and ideation, psychiatric symptoms, functioning, treatment utilization, problem-solving, belongingness, and cost-effectiveness.

Conditions Studied

Interventions

  • BEHAVIORAL Safety Planning Intervention

Study Locations (2)

Michigan

  • Genesee County Jail - Flint

Rhode Island

  • Rhode Island Department of Corrections - Cranston

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2016-04-01
Est. Completion 2019-12-31
Phase NA

Sponsor

Michigan State University

120 total trials

What the Registry Record Tells You About NCT02759172

The ClinicalTrials.gov registry entry for NCT02759172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,981-participant average among 92 other Suicide trials with a reported enrollment target (89% lower). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Safety Planning Intervention is the first listed.

NCT02759172 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02759172 about?

NCT02759172 is a clinical study titled "Suicide Prevention Intervention for At-Risk Individuals in Transition". The four year SPIRIT Trial, or Suicide Prevention Intervention for at-Risk Individuals in Transition, will recruit 800 pretrial jail detainees at risk for suicide. Each participant will be randomly assigned to today's standard care or to Safety Planning Intervention (SPI) method and then followed fo...

What is the current status of trial NCT02759172?

This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2016-04-01. Estimated completion is 2019-12-31.

What conditions does trial NCT02759172 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT02759172?

The interventions under investigation include: Safety Planning Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02759172?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02759172 being conducted?

This trial has 2 study locations across Michigan, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.